Table 2.
Longitudinal lung function in cases and controls by treatment group. Results are shown as median (interquartile range).
| Viral suppression | Untreated HIV | |||
|---|---|---|---|---|
| Cases n = 77 |
Controls n = 77 |
Cases n = 42 |
Controls n = 42 |
|
| FEV1 slope (mL/year) | − 86.0 (− 125.0, − 65.0) | − 3.0 (− 11.4, 10.0) | − 105.0 (− 160.0, − 76.3) | − 5.0 (− 11.5, 3.5) |
| FVC slope (mL/year) | − 65.6 (− 96.6, − 14.7) | 0 (− 32.3, 36.3) | − 61.0 (− 89.0, − 26.0) | − 5.0 (− 29.0, 22.0) |
| FEV1/FVC slope (% per year) | − 0.65 (− 1.16, − 0.04) | − 0.20 (− 0.57, 0.27) | − 0.53 (− 1.13, − 0.06) | − 0.45 (− 0.82, 0.14) |
| Number of FEV1 measurements | 4 (3, 4) | 4 (3, 5) | 3 (3, 4) | 4 (3, 4) |
FEV1 forced expiratory volume in 1-s, FVC forced vital capacity, mL milliliters.